Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Completed 6Active not recruiting 4Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 7Prostatic Neoplasms 4Neoplasms 2Motor Activity 2Urinary Bladder Neoplasms 1Sleep Wake Disorders 1Rectal Neoplasms 1Overweight 1Ovarian Neoplasms 1Obesity-Related Malignant Neoplasm 1Obesity 1No Evidence of Disease 1Kidney Neoplasms 1Hematopoietic and Lymphoid System Neoplasm 1Hematologic Neoplasms 1Head and Neck Carcinoma 1Financial Stress 1Fatigue 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Breast Carcinoma In Situ 1

Interventions

enzalutamide 33Abiraterone Acetate 28apalutamide 25Radiotherapy 25Prednisone 25Magnetic Resonance Spectroscopy 25Androgen Antagonists 24Leuprolide 21Radiosurgery 19darolutamide 18Docetaxel 17acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15Gonadotropin-Releasing Hormone 14gallium 68 PSMA-11 12Specimen Handling 12Goserelin 12pembrolizumab 11Radiotherapy, Intensity-Modulated 11Radiation 11bicalutamide 10abiraterone 10Pluvicto 10Carboplatin 9Brachytherapy 92-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 9relugolix 8luprolide acetate gel depot 8Standard of Care 8Nivolumab 8olaparib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Prostatic Neoplasms × Counseling × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT01410942 2026-02-20

Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
175 enrolled
Genitourinary

Fatigue, Prostatic Neoplasms

NCT03575832 2026-02-19

Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners

M.D. Anderson Cancer Center

Phase NA Active not recruiting
64 enrolled
Genitourinary

Prostatic Neoplasms

NCT00890006 2025-02-10

Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)

University Health Network, Toronto

Phase NA Active not recruiting
99 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡